CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Ares Trading against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Aug 7, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Methods Of Treating Cancer Using Pd-1 Axis Binding Antagonists And Tigit InhibitorsF HOFFMANN LA ROCHEApr 15, 2021
Recombinant Fsh Including Alpha 2,3- And Alpha 2,6-SialylationFERRINGMar 25, 2021
Therapeutic And Diagnostic Methods For CancerF HOFFMANN LA ROCHEDec 4, 2020
Methods Of Treating Cancers Using Pd-1 Axis Binding Antagonists And TaxanesFHOFFMANN LA ROCHEJul 23, 2020
Compositions And Methods For Targeted Immunomodulatory Antibodies And Fusion ProteinsTHE JOHNS HOPKINS UNIVERSITYFeb 2, 2018

Explore Ares Trading's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
Nov 16, 2022Process For The Purification Of Fc-Containing Proteins2
Aug 18, 2021Imaging And Evaluating Embryos, Oocytes, And Stem Cells1
Jul 22, 2020Liquid Pharmaceutical Composition3
Apr 22, 2020Patient Care System Reporting Adherence To Treatment Regimen1
Aug 29, 2018Use Of N-Acetyl-5-Methoxytryptamine Or Analogues Thereof, For Promoting The Mechanism Of Implantation Of The Embryo And Related Compositions And Culture Media1
Aug 22, 2018Liquid Pharmaceutical Composition1
Jun 27, 2018Liquid Pharmaceutical Composition2
Nov 1, 2017Method For Preparing Active Form Of Tnfr-Fc Fusion Protein1

Top competitors of Ares Trading

List of top competitors of Ares Trading based on patent oppositions.